{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:28:13Z","timestamp":1785875293899,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["181972468"],"award-info":[{"award-number":["181972468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cpt.2024.04.002","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T13:00:34Z","timestamp":1713358834000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Breast cancer risk associated with BRCA1 and BRCA2 pathogenic variants in the Eastern Chinese population"],"prefix":"10.1016","volume":"3","author":[{"given":"Sanjian","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8227-5056","authenticated-orcid":false,"given":"Zhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2024.04.002_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/87876","article-title":"Breast cancer genetics: What we know and what we need","volume":"7","author":"Nathanson","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.cpt.2024.04.002_bib2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cpt.2024.04.002_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.2007.55-a","article-title":"Variation of breast cancer risk among BRCA1\/2 carriers","volume":"299","author":"Begg","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cpt.2024.04.002_bib4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","article-title":"Characterization of BRCA1 and BRCA2 mutations in a large United States sample","volume":"24","author":"Chen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpt.2024.04.002_bib5","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1073\/pnas.1415979111","article-title":"Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2","volume":"111","author":"Gabai-Kapara","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cpt.2024.04.002_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1503523","article-title":"The role of risk-reducing surgery in hereditary breast and ovarian cancer","volume":"374","author":"Hartmann","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpt.2024.04.002_bib7","doi-asserted-by":"crossref","first-page":"T69","DOI":"10.1530\/ERC-16-0277","article-title":"Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers","volume":"23","author":"Milne","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.cpt.2024.04.002_bib8","first-page":"2","article-title":"Cancer incidence and mortality in China, 2015","volume":"1","author":"Zhang","year":"2021","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.cpt.2024.04.002_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-007-9708-3","article-title":"The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: Two recurrent mutations were identified","volume":"110","author":"Li","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cpt.2024.04.002_bib10","article-title":"Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cpt.2024.04.002_bib11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/ijc.32176","article-title":"Germline variation in BRCA1\/2 is highly ethnic-specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients","volume":"145","author":"Bhaskaran","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cpt.2024.04.002_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-020-01010-0","article-title":"Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort","volume":"14","author":"Liu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.cpt.2024.04.002_bib13","doi-asserted-by":"crossref","first-page":"25025","DOI":"10.18632\/oncotarget.24382","article-title":"Breast and ovarian cancer penetrance of BRCA1\/2 mutations among Hong Kong women","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cpt.2024.04.002_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10549-016-3766-3","article-title":"Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations","volume":"156","author":"Yao","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cpt.2024.04.002_bib15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/94.16.1221","article-title":"On the use of familial aggregation in population-based case probands for calculating penetrance","volume":"94","author":"Begg","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cpt.2024.04.002_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21037\/pcm-22-36","article-title":"Protocol: Screening of genetic susceptibility genes for breast cancer patients and establishment of genetic high-risk populations cohort in east china communities","volume":"5","author":"Wang","year":"2022","journal-title":"Precis Cancer Med"},{"key":"10.1016\/j.cpt.2024.04.002_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.0006-341X.2001.00245.x","article-title":"A marginal likelihood approach for estimating penetrance from kin-cohort designs","volume":"57","author":"Chatterjee","year":"2001","journal-title":"Biometrics"},{"key":"10.1016\/j.cpt.2024.04.002_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/aje\/148.7.623","article-title":"The kin-cohort study for estimating penetrance","volume":"148","author":"Wacholder","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cpt.2024.04.002_bib19","series-title":"Shanghai cancer report 2017. Shanghai Municipal Center for Disease Control and Prevention Scientific Report","year":"2017"},{"key":"10.1016\/j.cpt.2024.04.002_bib20","series-title":"Hong Kong Female Breast Cancer in 2019: Hong Kong Cancer Registry","year":"2021"},{"key":"10.1016\/j.cpt.2024.04.002_bib21","series-title":"Beijing Municipal People\u2019s Government. Beijing municipal health and population health report","year":"2013"},{"key":"10.1016\/j.cpt.2024.04.002_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpt.2024.04.002_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/djj012","article-title":"Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920\u20132000","volume":"98","author":"Tryggvadottir","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cpt.2024.04.002_bib24","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cpt.2024.04.002_bib25","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/IGC.0000000000001065","article-title":"The first nationwide multicenter prevalence study of germline BRCA1 and BRCA2 mutations in Chinese ovarian cancer patients","volume":"27","author":"Wu","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cpt.2024.04.002_bib26","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada","volume":"98","author":"Risch","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cpt.2024.04.002_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cpt.2024.04.002_bib28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.21.02112","article-title":"Cancer risks associated with BRCA1 and BRCA2 pathogenic variants","volume":"40","author":"Li","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpt.2024.04.002_bib29","series-title":"Familial breast cancer: Classification, care and managing breast cancer and related risks in people with a family history of breast cancer","year":"2019"},{"key":"10.1016\/j.cpt.2024.04.002_bib30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jnci\/djr114","article-title":"Confirmation of family cancer history reported in a population-based survey","volume":"103","author":"Mai","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cpt.2024.04.002_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1200\/JCO.2013.51.4661","article-title":"Quality of cancer family history and referral for genetic counseling and testing among oncology practices: A pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative","volume":"32","author":"Wood","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpt.2024.04.002_bib32","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.2014.5985","article-title":"Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer","volume":"313","author":"Rebbeck","year":"2015","journal-title":"JAMA"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713224000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713224000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:51:14Z","timestamp":1778935874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713224000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2949713224000260"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2024.04.002","relation":{},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer risk associated with BRCA1 and BRCA2 pathogenic variants in the Eastern Chinese population","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2024.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}